BMT Stock Overview
Provides artificial intelligence-based decision support software and data insight services to healthcare industry in Australia and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Beamtree Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.24 |
| 52 Week High | AU$0.37 |
| 52 Week Low | AU$0.17 |
| Beta | 1.96 |
| 11 Month Change | -4.00% |
| 3 Month Change | -18.64% |
| 1 Year Change | 9.09% |
| 33 Year Change | -52.00% |
| 5 Year Change | 23.08% |
| Change since IPO | 29.73% |
Recent News & Updates
Recent updates
Shareholder Returns
| BMT | AU Healthcare Services | AU Market | |
|---|---|---|---|
| 7D | 0% | 3.6% | 0.4% |
| 1Y | 9.1% | 118.2% | 16.9% |
Return vs Industry: BMT underperformed the Australian Healthcare Services industry which returned 121% over the past year.
Return vs Market: BMT underperformed the Australian Market which returned 16.9% over the past year.
Price Volatility
| BMT volatility | |
|---|---|
| BMT Average Weekly Movement | 8.1% |
| Healthcare Services Industry Average Movement | 8.2% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in AU Market | 17.4% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: BMT has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: BMT's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 97 | Tim Kelsey | beamtree.com.au |
Beamtree Holdings Limited provides artificial intelligence-based decision support software and data insight services to healthcare industry in Australia and internationally. It operates through four segments: Diagnostic Technology; Clinical Decision Support; Coding Assistance and Data Quality; and Analytics and Knowledge Networks. The company offers RippleDown Expert, a CDS system that provides treatment recommendations, real-time alerts, and advanced reflex and appropriate testing recommendations; RippleDown Auditor, that automates real-time reviews of data, ensuring accuracy across data entry, billing, specimen reception, and flagging suspected errors; and PICQ, a quality assessment tool for clinically coded data.
Beamtree Holdings Limited Fundamentals Summary
| BMT fundamental statistics | |
|---|---|
| Market cap | AU$69.54m |
| Earnings (TTM) | -AU$5.11m |
| Revenue (TTM) | AU$27.60m |
2.5x
P/S Ratio-13.6x
P/E RatioIs BMT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BMT income statement (TTM) | |
|---|---|
| Revenue | AU$27.60m |
| Cost of Revenue | AU$22.71m |
| Gross Profit | AU$4.89m |
| Other Expenses | AU$10.00m |
| Earnings | -AU$5.11m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.018 |
| Gross Margin | 17.72% |
| Net Profit Margin | -18.50% |
| Debt/Equity Ratio | 1.1% |
How did BMT perform over the long term?
See historical performance and comparison